Partnering with Harvard Medical School

The Trillion-Dollar Moat: Building the Safety OS for Humanoid Healthcare

The Problem: 1.6 billion seniors by 2050, zero caregivers. Affordable humanoids exist, but deploying them creates catastrophic liability without certification.

The Solution: Safety-OS™ — the FDA-ready software brain that makes humanoid caregivers safe, compliant, and deployable.

ENTER INVESTOR DATA ROOM →

The Ask

Raising $6M Seed: $3M US + $3M EU dual-track regulatory pilots
First-mover advantage in trillion-dollar humanoid healthcare market
Harvard Medical School partnership (December 2025) de-risks execution

$6M Seed Ask

49× ROI Projection

$279M NPV (10 years)

Year 4 Payback Period

Why We Win

Regulatory moat: 7 compliance standards (ISO 13485, IEC 62304, HIPAA, FDA 21 CFR Part 11) take competitors 3-5 years and $10M+ to replicate
Hardware-agnostic platform: Plug into Unitree, Boston Dynamics, any humanoid OEM
Physician-in-the-Loop architecture: Solves liability crisis by keeping clinicians in control
4-layer revenue model: Professional services, SaMD licensing ($15K-$25K/robot/year), DaaS, platform fees — 85%+ gross margins at scale

The Founder

Andy Squire: 4 domains of expertise — AI Healthcare IT (Oxford/INSEAD/Cambridge), Pharma CX Strategy, Regulatory Compliance (SaMD, FDA, ISO 13485), EHR Integration (FHIR)
Independent patient advocate: 2× cancer survivor — trusted to put patients over profit
Harvard Medical School partnership: Immediate placement offered (December 2025) for commercial innovation track

Ready to Invest in the Regulatory Bridge for Humanoid Healthcare?

Join the trillion-dollar revolution. Access the full investor deck, financials, and technical specifications.

ENTER INVESTOR DATA ROOM →